Pei-Jen Chang

Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and <i>BRCA1</i>/<i>2</i> Mutation–Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105

Melinda L. Telli, Kristin C. Jensen, Shaveta Vinayak et al. · Journal of Clinical Oncology · 2015 · 225 citations · Full text

Maternal return to work and breastfeeding: A population-based cohort study

Chao-Hua Chuang, Pei-Jen Chang, Yi-Chun Chen et al. · International Journal of Nursing Studies · 2009 · 129 citations

Nursing, Family Medicine, Lactation +12

Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancer

Melinda L. Telli, Jessica A. Hellyer, William Audeh et al. · Breast Cancer Research and Treatment · 2017 · 128 citations

Homologous Recombination Deficiency, Breast Oncology, Medicine +7

Herbal Medicines Used During the First Trimester and Major Congenital Malformations

Chao-Hua Chuang, Pat Doyle, Jung‐Der Wang et al. · Drug Safety · 2006 · 90 citations

Herbal Medicines, First Trimester, Infertility +11

Working hours and risk of gestational hypertension and pre-eclampsia

Pei-Jen Chang, Lily Chu, Wu‐Shiun Hsieh et al. · Occupational Medicine · 2009 · 33 citations · Full text